Table 4.
Group | n | COL I (%) | COL III (%) |
Control | 16 | 0.47±0.05 | 0.40±0.03 |
Hepatic fibrosis | 12 | 4.18±2.26b | 3.04±0.62b |
Non-DSHX-treated | 10 | 3.22±1.44b | 2.23±0.58bc |
DSHX-treated | 10 | 1.07±0.96df | 1.09±0.58df |
P<0.01 vs normal control group;
P<0.05,
P<0.01 vs hepatic fibrosis group;
P<0.01 vs non-DSHX-treated group.